Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
46.4M
-
Number of holders
-
128
-
Total 13F shares, excl. options
-
22.2M
-
Shares change
-
+1.54M
-
Total reported value, excl. options
-
$442M
-
Value change
-
+$30.7M
-
Number of buys
-
69
-
Number of sells
-
-39
-
Price
-
$19.90
Significant Holders of Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) as of Q4 2018
132 filings reported holding AMPH - Amphastar Pharmaceuticals, Inc. - Common Stock as of Q4 2018.
Amphastar Pharmaceuticals, Inc. - Common Stock (AMPH) has 128 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.2M shares
of 46.4M outstanding shares and own 47.92% of the company stock.
Largest 10 shareholders include BlackRock Inc. (5.93M shares), Vanguard Group Inc (2.29M shares), DIMENSIONAL FUND ADVISORS LP (1.9M shares), FEDERATED INVESTORS INC /PA/ (1.36M shares), Invesco Ltd. (1.11M shares), STATE STREET CORP (1.02M shares), TEACHERS ADVISORS, LLC (567K shares), NORTHERN TRUST CORP (473K shares), Bank of New York Mellon Corp (447K shares), and GEODE CAPITAL MANAGEMENT, LLC (425K shares).
This table shows the top 128 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.